Zobrazeno 1 - 10
of 88
pro vyhledávání: '"M.R.G. Robinson"'
Autor:
M. Pavone-Macaluso, D.Di Trapani, C. Pavone, F. Piaia, F. Rocco, L. Denis, C. Bouffioux, H. de Voogt, T. Becopoulos, D. Newling, P.H. Smith, M.R.G. Robinson
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 25:77-82
Autor:
Jonas Hugosson, Jacques Bernstein, D.C. Hanbury, Herbert Leyh, Hsueh-Fu Lu, Yuh-Shyan Tsai, Peter R. Mazal, Karl Fastenmeier, Gunnar Aus, H.-P. Caspers, A.C. Woodman, Chien-Cheng Chang, Martin Susani, C. Liapi, Lisa Sengeløv, Ezekiel H. Landau, Michel Soulié, S.K. Sundaram, G.B. Boustead, Erik Pileblad, Prodromos G. Borboroglu, Andrea Haitel, Assma Benaïssa, Philippe Seguin, Hans von der Maase, J. Hetherington, Pierre Plante, Richard Berges, Régis Soulié, Jean-Marc Larroque, Hong-Lin Cheng, M.R.G. Robinson, Mathias Barba, U. Jonas, T. Senge, Christophe Tollon, Peter Iversen, Roland Sedivy, A. Saad, H.B. Joshi, P.C. Tam, Hsi-Chin Wu, M.C. Cheung, Pär Lodding, F. Sommer, P.N. Rao, Yeong-Chin Jou, Patrick Mouly, L. Kisbenedek, U. Engelmann, Wen-Chi Chen, O.O. Obadeyi, S. Adams, Claus Kamby, Johnny Shinn Nan Lin, L. Pientka, Per-Anders Abrahamsson, Pontonnier F, F. Lee, Philippe Brucher, T.A. McNicholas, Rudolf Hartung, Christopher L. Amling, Amos Shapiro, Ewald Moser, Svante Bergdahl, K. Höfner, T. Klotz, Tzong-Shin Tzai, Wen-Horng Yang, D.W.W. Newling, U. Schwarzer, Ofer Z. Shenfeld, Nicolas Vazzoler, Dov Pode, Ofer N. Gofrit, Huey-Yi Chen, Bob Djavan, Yat-Ching Tong, Nahum Kovalski, Carl-Gustaf Pihl, S.K.H. Yip, Christian Windischberger, G. Haupt, Fuu-Jen Tsai, Yung-Ming Lin, Peter F.A. Mulders, Xavier Cuvillier
Publikováno v:
European Urology. 39:728-729
Autor:
Mathias Barba, Pontonnier F, T. Klotz, Jean-Marc Larroque, Tzong-Shin Tzai, Peter Iversen, Wen-Horng Yang, T.A. McNicholas, Hong-Lin Cheng, U. Engelmann, Christopher L. Amling, Svante Bergdahl, Andrea Haitel, P.C. Tam, Yeong-Chin Jou, A. Saad, Johnny Shinn Nan Lin, Herbert Leyh, Martin Susani, Philippe Seguin, M.C. Cheung, Carl-Gustaf Pihl, O.O. Obadeyi, S. Adams, Yuh-Shyan Tsai, H.B. Joshi, Xavier Cuvillier, Michel Soulié, Jacques Bernstein, G.B. Boustead, T. Senge, Pär Lodding, Lisa Sengeløv, Ezekiel H. Landau, P.N. Rao, U. Jonas, Karl Fastenmeier, Hsueh-Fu Lu, Jonas Hugosson, C. Liapi, M.R.G. Robinson, J. Hetherington, Patrick Mouly, Assma Benaïssa, Ewald Moser, Peter F.A. Mulders, Hans von der Maase, Chien-Cheng Chang, Christophe Tollon, Richard Berges, Gunnar Aus, L. Pientka, H.-P. Caspers, S.K. Sundaram, S.K.H. Yip, Prodromos G. Borboroglu, Amos Shapiro, A.C. Woodman, L. Kisbenedek, F. Lee, Philippe Brucher, Rudolf Hartung, Roland Sedivy, F. Sommer, Yung-Ming Lin, Christian Windischberger, G. Haupt, Fuu-Jen Tsai, Erik Pileblad, Pierre Plante, Régis Soulié, Claus Kamby, D.C. Hanbury, Wen-Chi Chen, Peter R. Mazal, Ofer N. Gofrit, Hsi-Chin Wu, Huey-Yi Chen, Per-Anders Abrahamsson, K. Höfner, Bob Djavan, D.W.W. Newling, Ofer Z. Shenfeld, Nicolas Vazzoler, Yat-Ching Tong, Nahum Kovalski, U. Schwarzer, Dov Pode
Publikováno v:
European Urology. 39:731-731
Publikováno v:
European Urology. 8:32-36
The levels of serum acute phase reactant proteins (APRPs) have been examined in untreated kidney carcinoma and during the evolution of metastases. These proteins can provide a warning of the likelihood of extensive local or metastatic spread at first
Publikováno v:
Clinica Chimica Acta. 113:27-34
An enzyme immunoassay for prostatic acid phosphatase (PAP) has been assessed. An upper limit normal is set at 1.8 microgram/1. There is a very low incidence of raised levels in chronic diseases or cancers other than those of the prostate. Patients wi
Autor:
B. Van Der Werf-Messing, M.R.G. Robinson, B. Richard, Edward H. Cooper, Sarah Haworth, W. G. Haije, J. O'Quigley
Publikováno v:
European Journal of Cancer (1965). 17:251-255
This study demonstrates that the survivial of patients with UICC category T3 and T4 bladder cancer is strongly correlated with pre-treatment levels of serum acute phase reactant proteins and albumin. A more accurate assessment of the prognosis is obt
Publikováno v:
European Journal of Cancer and Clinical Oncology. 25:1255-1257
Autor:
S. Dris, Keith Griffiths, A. Turkes, K.J. Walker, Robert Ian Nicholson, M.R.G. Robinson, A.O. Turkes, Z. Crispin
Publikováno v:
Lancet (London, England). 2(8347)
8 patients with advanced prostatic carcinoma were treated with the luteinising-hormone releasing-hormone agonist, ICI 118630, for up to 3 months. Patients received subcutaneous injections of ICI 118630 (either 100 micrograms or 250 micrograms daily).
Publikováno v:
European urology. 12(2)
Serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) were evaluated with double monoclonal radioimmunoassays. In 250 patients with prostatic cancer the normal limits were as follows: PSA 0.1-2.7 ng/ml, and PAP 1.09 +/- 0.45 ng/
Autor:
M.R.G. Robinson, Roger W. Blamey, Keith Griffiths, A.O. Turkes, K.J. Walker, A. Turkes, Robert Ian Nicholson, F.C. Campbell, J. Dyas
Publikováno v:
Journal of steroid biochemistry. 20(1)
The influence of the LH-RH agonist ICI 118630 on circulating levels of the pituitary gonadotrophins LH and FSH and the gonadal steroids oestradiol, progesterone, 17-hydroxyprogesterone and testosterone has been studied in phase I clinical trials of t